The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 10, 2002, Pages 1723-1731

  Annibale, B ^a,c   Di Giulio, E ^a   Caruana, P ^b   Lahner, E ^a   Capurso, G ^b   Bordi, C ^a   Delle Fave, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c POLICLINICO UMBERTO I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; GASTRIN; METRONIDAZOLE; PENTAGASTRIN; PEPSINOGEN I;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ATROPHIC GASTRITIS; CLINICAL ARTICLE; FEMALE; GASTRIN BLOOD LEVEL; GASTROSCOPY; HELICOBACTER INFECTION; HISTOLOGY; HUMAN; INTESTINE METAPLASIA; MALE; PRIORITY JOURNAL; STOMACH ACID SECRETION; STOMACH BIOPSY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; FEMALE; FOLLOW-UP STUDIES; GASTRIC ACID; GASTRIC MUCOSA; GASTRINS; GASTRITIS, ATROPHIC; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPSINOGEN A; PROSPECTIVE STUDIES;

EID: 0036791284     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01336.x     Document Type: Article

References (35)

1. Fong TL, Dooley CP, Dehesa M, et al. Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology 1991; 100: 328-32.
2. Pérez-Pérez GI. Role of Helicobacter pylori infection in the development of pernicious anaemia. Clin Infect Dis 1997; 25: 1020-2.
3. Annibale B, Lahner E, Bordi C, et al. Role of Helicobacter pylori infection in pernicious anemia. Digest Liver Dis 2000; 32: 756-63.
4. Weinstein WM. Other types of gastritis and gastropathies. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal Disease. 6th edn. Philadelphia: W. B. Saunders. 1998: 711-32.
5. Peterson WL, Graham DY. Helicobacter pylori. In: Feldman M. Scharschmidt BF, Sleisenger MH, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 6th edn. Philadelphia: W. B. Saunders. 1998: 604-19.
6. Annibale B, Marignani M, Azzoni C, et al. Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter 1997; 2: 57-64.
7. Annibale B, Negrini R, Caruana P, et al. Two thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection. Helicobacter 2001; 6: 225-34.
8. Tucci A, Biasco G, Paparo GF. Effect of eradication of Helicobacter pylori in patients with fundic atrophic gastritis. N Engl J Med 1997; 336: 957-8.
9. El-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113; 15-24.
10. Annibale B, Aprile MR, D'Ambra G, et al. Cure of Helicobacter pyori infection in atrophic body gastritis patients does not determine an improvement of mucosal atrophy but reduces hypergastrinaemia and its related effects on body ECL ceil hyperplasia. Aliment Pharmacol Ther 2000; 14: 625-34.
11. Haruma K, Mihara M, Okamoto E, et al. Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus: evaluation of 24-h pH monitoring. Aliment Pharmacol Ther 1999; 13: 155-62.
12. Domellof L. Reversal of gastric atrophy after Helicobacter pylori eradication: is it possible or not. Am J Gastroenterol 1998; 93: 1407-8.
13. Oberhuber G, Wuendisch T, Rappel S, Stolte M. Significant improvement of atrophy after eradication therapy in atrophic body gastritis. Pathol Res Pract 1998; 194: 609-13.
14. Tucci A, Poll L, Tosetti G, et al. Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol 1998; 93: 1425-31.
15. Ohkusa T, Fujiki K, Takashimizu I, et al. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001; 134: 380-6.
16. Satoh K, Kimura K, Takimoto T, et al. A follow-up study of atrophic gastritis and intestinal metaplasia after the eradication of Helicobacter pylori. Helicobacter 1998; 3: 236-40.
17. Genta RM, Ginger ML, Graham DY. Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol 1993; 6: 281-9.
18. Genta RM, Helicobacter pylori, inflammation, mucosal damage and apoptosis: Pathogenesis and definition of gastric atrophy. Gastroenterology 1997; 113: S51-5.
19. Lahner E, Bordi E, Di Giulio E, et al. Role of Helicobacter pylori serology in atrophic body gastritis after eradication treatment. Aliment Pharmacol Ther 2002; 16: 507-14.
20. Bordi C, Annibale B, Azzoni C, et al. Endocrine cell growths in atrophic body gastritis. Critical evaluation of a histological classification. J Pathol 1997; 182: 339-46.
21. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 1996; 20: 1161-81.
22. Delle Fave G, Kohn A, de Magistris L, et al. Effects of bombesin on gastrin and gastric acid secretion in patients with duodenal ulcer. Gut 1983; 24: 231-5.
23. Annibale B, de Magistris L, Corleto V, et al. Zollinger-Ellison syndrome and antral G-cell hyperfunction in patients with resistant duodenal ulcer disease. Aliment Pharmacol Ther 1994; 8: 87-93.
24. Samloff IM, Varis K, Ihamaki T, et al. Relationship among serum pepsinogen I, serum pepsinogen II and gastric mucosal history. A study in relatives of patients with pernicious anemia. Gastroenterology 1982; 83; 204-9.
25. El-Omar EM. The importance of interleukin 1 β in Helicobacter pylori associated disease. Gut 2001; 48: 743-7.
26. Kondo S, Shimura Y, Kanayama S, et al. Interleukin 1 beta inhibits gastric histamine secretion and synthesis in rat. Am J Physiol 1994; 267: G966-71.
27. Yasunaga Y, Shinomura Y, Kanayama S, et al. Mucosal interleukin 1 beta production and acid secretion in enlarged fold gastritis. Aliment Pharmacol Ther 1997; 11: 801-9.
28. Taguchi Y, Kaito M, Gabazza EC, et al. Helicobacter pylori inhibits the secretory activity of gastric parietal cells in patients with chronic gastritis. Scand J Gastroenterol 1997; 32: 656-63.
29. Furuta T, Baba S, Takashima M, et al. Effect of Helicobacter pylori infection on gastric juice pH. Scand J Gastroenterol 1998; 33: 357-63.
30. Feldman M, Cryer B, Lee E. Effects of Helicobacter pylori gastritis on gastric secretion in healthy human beings. Am J Physiol 1998; 274: G1011-7.
31. McGowan CC, Cover TL, Blaser MJ. Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology 1996; 110: 926-38.
32. Sung JJY, Lin S-R, Ching JYL. et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000; 119: 7-14.
33. Genta RM, Rugge M. Gastric precancerous lesions: heading for an international consensus. Gut 1999; 45(Suppl. 1): 15-8.
34. Dixon MF. Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia. Gut 2001; 49: 2-4.
35. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.